4 funding opportunities are listed in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest
Muscular Dystrophy Association Research Infrastructure Grant
The Infrastructure Grant is designed to fund the development of infrastructure — tools, techniques or services — that will be of use to the neuromuscular disease research community for the purpose of therapy development. Although the need for the proposed infrastructure can be presented in the context of a specific research project or projects, the grant will ultimately be evaluated on the need for the infrastructure by the community at large, and on the applicant’s specific plan for making this resource available to the community. Collaboration and compatibility of the proposal with relevant existing infrastructure is encouraged.
Letter of Intent: September 15, 2010 Grant Application: October 15, 2010 Start Date: July 1, 2011
The applicant should be a professional or faculty member at an appropriate educational, medical or research institution who is qualified to conduct and supervise a program of original research. The applicant should hold a Doctor of Medicine, Doctor of Philosophy, Doctor of Science or equivalent degree.
Examples of acceptable infrastructure projects include, but are not limited to, development of databases, core facilities (e.g., vector production, muscle imaging, drug screening), microarray chips, animal model resources, tissue repositories, and components of clinical research networks.
Contact Elizabeth Habeeb-Louks 3300 E. Sunrise Drive Tucson, AZ 85718 (520) 615-6704 (520) 529-5454 (fax) elouks@mdavp.org
Muscular Dystrophy Association Research Grants Programs
MDA supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system. These are the muscular dystrophies (among which are Duchenne and Becker); motor neuron diseases (including ALS and SMA); the peripheral nerve disorders (CMT and Friedreich's ataxia); inflammatory myopathies; disorders of the neuromuscular junction; metabolic diseases of muscle as well as other myopathies.
RESEARCH GRANT
To be eligible to apply for an MDA research grant, an applicant must:
1. Hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.); 2. Be a professional or faculty member (Professor, Associate Professor or Assistant Professor) at an appropriate educational, medical or research institution; 3. Be qualified to conduct and mentor a program of original research within their own laboratory; 4. Assume both administrative and financial responsibility for the grant; and 5. Have access to institutional resources necessary to conduct the proposed research project.
Proposals from applicants outside the United States will be considered for projects of highest priority to MDA and when, in addition to the applicant's having met the requirements noted above the applicant's country of residence may not have adequate sources of financial support for biomedical research.
NOTE: To apply for a Research Grant, you must be an independent investigator, i.e., not a trainee, not a post-doctoral fellow, not a research assistant, not a research associate and not under the supervision of another person (Principal Investigator/Independent Investigator) who is directing the research.
DEVELOPMENT GRANT
MDA will consider an application for a research grant from a candidate who may be a member of a research team in the laboratory of an independent investigator (Principal Investigator) under whose guidance the applicant will be given flexibility to conduct a neuromuscular disease research project.
To be eligible for a Development Grant, an applicant must:
1. Hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.); 2. Be a member of a research team at an appropriate institution; 3. Be qualified to conduct a program of original research under the supervision of a Principal Investigator; 4. Have an acceptable research plan for a specific disease in MDA's program; 5. Have access to institutional resources necessary to conduct the proposed research project; and 6. Have eighteen (18) months of post-doctoral research laboratory training at the time of application, but no more than 5 years (60 months).
TENURE
Awards are for either one, two or three years for all grant types.
AWARDS
Funding levels for primary Research Grants are unlimited. Development grants are a maximum of $60,000 per year. Overhead is limited to a maximum of 10% percent of direct costs to be included in the total amount of the grant request.
APPLICATION PROCEDURE
A pre-proposal form must be submitted through proposalCENTRAL® to formally request an application for an MDA research grant. Requests for applications can be submitted anytime prior to the applicable deadline date.
Applications are not open to institutions for general distribution.
Only two grant review rounds are held each year. Only one "letter of intent" is permitted per grant review round.
Deadline dates
Spring Review Letter of Intent: December 15
Fall Review Letter of Intent: June 15
Muscular Dystrophy Association Grants Manager - Research Department 3300 E. Sunrise Drive Tucson, AZ 85718 (520) 529-2000 (520) 529-5454 (fax) grants@mdausa.org
Spring Review Letter of Intent: December 15 Fall Review Letter of Intent: June 15
Cure Congenital Muscular Dystrophy Research Grants
Cure CMD Research Grant GoalsCure CMD research goals reflect our mission to bring research, treatments and in the future, a cure for the congenital muscular dystrophies. 1. Identify new therapeutic targets in the CMDs 2. Identify small molecule compounds that work at these therapeutic target sites with priority towards drugs with existing pediatric FDA approval 3. Facilitate the drug development process to ensure that each positive drug identification with promising preliminary data can be brought rapidly to preclinical trials and subsequent treatment trials 4. Support and endorse clinical research, infrastructure and biomarker discovery required to launch effective and efficient clinical trials in rare disease 5. Advance drug discovery with a diverse treatment pipeline 6. Support new scientific investigators with innovative ideas and a commitment to CMD researchStruggle Against Muscular Dystrophy (S.A.M) CMD Translational Research Grant: Annual Deadline, Sept 15th.
S.A.M is a unique CMD advocacy group launched by two parents whose son has CMD. SAM’s focus is to support and foster CMD research through successful fundraising initiatives. The SAM Translational Research Award delivers upon its promise to target research focused on CMD treatment. The grant is made possible through Cure CMD and SAM collaboration and the Cure CMD research grant funding mechanism.Cure CMD and SAM invite proposals to award a 1-2 year grant focusing on pre-clinical and clinical investigations that will advance treatment for congenital muscular dystrophy (CMD). The total award is limited to $100,000 (direct costs only). Annual RFA deadline Sept 15th. Grant application above. On the First Page of the Cure CMD grant application, please specify S.A.M. CMD Translational Research Grant
Cure CMD General Research Grants: Annual Deadline Sept 15th.
Elisabeth Giauque Short Term CMD Research Grant: Cure CMD provides a short-range or “seed” grant (usually $25,000- $50,000 per year for 1-2 years, direct costs only) to attract new investigators to the CMD field and assist existing investigators to support early phases of their research. The short-range grant focus is to collect preliminary data and test initial hypotheses. The short-range grant goal is to translate successful preliminary research to either second tier Cure CMD midrange grants (R-21 type) or third tier, long range (R-01 grants, 2-5 years) from outside funding sources, such as the National Institutes of Health. Annual RFA deadline, Sept 15th. Grant application above. On the first page of the Cure CMD grant application, please specify Elisabeth Giauque Short Term CMD Research Grant.
info@curecmd.comCure CMDP.O. Box 701Olathe, KS 66051Ph. 1-866-400-3626
1